Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT05518253
Recruiting
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1 · China · 1 site
Registry update: 31 May 2025
NCT05366881
Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Not applicable · United States · 17 sites
Registry update: 4 Nov 2026
NCT05092373
Recruiting
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
Phase 1 · United States · 1 site
Registry update: 16 Jul 2026
NCT06357416
Recruiting
The Man Van Project
Not applicable · United Kingdom · 1 site
Registry update: 1 May 2024
NCT05329532
Recruiting
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
Phase 1/2 · United Kingdom · 16 sites
Registry update: 17 Sept 2025
NCT05267626
Recruiting
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Phase 1/2 · Australia, United States · 17 sites
Registry update: 18 Sept 2026
NCT05269381
Recruiting
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/2 · United States · 1 site
Registry update: 20 Aug 2026
NCT05287464
Recruiting
International Multicentric Study ARON-1
Not applicable · Italy · 1 site
Registry update: 26 Nov 2025
NCT05621837
Recruiting
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Not applicable · Italy · 1 site
Registry update: 2 May 2025
NCT05214885
Recruiting
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
Not applicable · China · 1 site
Registry update: 9 Mar 2022
NCT05023265
Recruiting
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
Not applicable · Canada · 1 site
Registry update: 28 Apr 2026
NCT07062549
Recruiting
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
Phase 1 · United States · 1 site
Registry update: 21 Jul 2026
NCT05263050
Recruiting
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Phase 2 · United States · 1 site
Registry update: 28 Jul 2026
NCT05363657
Recruiting
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Not applicable · Austria, Belgium, Brazil, Spain, United Kingdom, Greece, Italy, Japan, Netherlands, Poland, Russia, Singapore, United States · 37 sites
Registry update: 6 May 2022
NCT05176483
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 1 · Austria, Australia, Belgium, Switzerland, Germany, Spain, France, United Kingdom, Israel, Italy, New Zealand, Poland, United States · 114 sites
Registry update: 1 Oct 2026
NCT04823923
Recruiting
Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer
Not applicable · France · 5 sites
Registry update: 12 Feb 2025
NCT05037825
Recruiting
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Not applicable · United States · 1 site
Registry update: 27 Apr 2022
NCT05024214
Recruiting
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Phase 1/2 · China · 23 sites
Registry update: 25 Mar 2026
NCT04851119
Recruiting
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/2 · United States · 21 sites
Registry update: 25 Aug 2026
NCT04981119
Recruiting
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Not applicable · United States · 16 sites
Registry update: 26 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.